The Department of Breast Surgery manages the full spectrum of breast diseases. For benign conditions, we treat fibroadenomas, intraductal papillomas, galactoceles, and other common lesions. For malignant diseases, we specialize in early diagnosis and individualized treatment of breast cancer. Our surgical portfolio includes nipplesparing mastectomy (NSM) with immediate reconstruction using a pedicled latissimus dorsi myocutaneous flap – a procedure in which we have accumulated experience in more than 1,000 such cases. We also offer immediate or delayed breast reconstruction with implants, transverse rectus abdominis myocutaneous (TRAM) flaps, and deep inferior epigastric perforator (DIEP) flaps. For appropriately selected patients, we perform oncoplastic breastconserving surgery to achieve both oncological safety and optimal cosmetic outcomes.We have particular expertise in treating refractory locally advanced breast cancer, plasma cell mastitis, gynecomastia, and macromastia requiring reduction mammoplasty. Our multidisciplinary approach ensures that even the most complex cases receive thorough evaluation and customized treatment strategies.Routinely, we perform ultrasound-guided vacuum-assisted biopsy, segmental mastectomy, lumpectomy, modified radical mastectomy, breast-conserving surgery, and sentinel lymph node biopsy. In parallel, we are at the forefront of breast oncoplastic techniques, including immediate/delayed reconstruction and endoscopic surgery for gynecomastia. Our team also offers supermicrosurgical lymphaticovenous anastomosis to treat peripheral lymphedema, a common complication following breast cancer therapy. Comprehensive and Multidisciplinary Care Beyond surgery, we provide personalized systemic therapies – neoadjuvant chemotherapy, adjuvant chemotherapy, endocrine therapy, and targeted therapy – based on the latest evidence. Our department maintains a regular multidisciplinary team (MDT) collaboration with medical oncology, radiology, ultrasound, and pathology. These weekly conferences allow every patient to benefit from a consensusbased treatment plan, aimed at improving longterm survival and enhancing quality of life.